Wg. North et al., AN EVALUATION OF HUMAN NEUROPHYSIN PRODUCTION IN ALZHEIMERS-DISEASE -PRELIMINARY-OBSERVATIONS, Neurobiology of aging, 13(2), 1992, pp. 261-265
The concentrations of human neurophysins in the cerebrospinal fluid (C
SF) of nine patients with Alzheimer's disease: Preliminary observation
s. (AD), and one patients with Pick's disease, were determined using s
pecific radioimmunoassays (RIAs). Concentrations of vasopressin and ox
ytocin were also measured. Values were compared with those from 20 age
-matched mentally normal individuals who were being treated for back p
ain. CSF levels of vasopressin-associated human neurophysin (VP-HNP) a
nd oxytocin-associated human neurophysin (OT-HNP) in patients with AD
(22 +/- 4 fmol/ml and 104 +/- 17 fmol/ml) were only 42% and 58% of tho
se in the control subjects (p < 0.0001, p < 0.0004). Vasopressin level
s for these patients (3.6 +/- 0.4 fmol/ml) were also significantly red
uced to 51% of controls (p < 0.007) and oxytocin levels were marginall
y (p = 0.092) reduced to 70% of controls. Because neurophysins and neu
ropeptides are gene-related products of vasopressin-neurons and oxytoc
in-neurons, the data indicate that these neurons are functionally impa
ired in patients with AD. Plasma neurophysin values suggest this impai
rment is confined to neurons with centrally-directed axons. Data from
the one patient with Pick's disease demonstrates that reduced CSF leve
ls of neurophysins and hormones is not confined to Alzheimer-type deme
ntia.